| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/30/1992 | EP0505846A1 Process for converting fused protein into active type human motilin analogues and purifying the analogues |
| 09/30/1992 | EP0505817A1 Use of phosphatidylserine and its derivatives for the manufacture of a medicament for the treatment of degenerative pathologies also associated with immune disfunctions |
| 09/30/1992 | EP0505811A2 Improved acidic fibroblast growth factor (aFGF) and its preparation |
| 09/30/1992 | EP0505749A2 Monoclonal antibodies directed to activated endothelial cells and their therapeutic and diagnostic use |
| 09/30/1992 | EP0505735A1 Antibiotic A 40926 ester derivatives |
| 09/30/1992 | EP0505680A1 Octapeptide or heptapeptide derivatives, a process for preparing them as well as medicaments containing these compounds and the use of them |
| 09/30/1992 | EP0505604A1 Highly purified thrombin preparation |
| 09/30/1992 | EP0505552A1 Megakaryocyte maturation factors |
| 09/30/1992 | EP0505497A1 Wound treatment employing biologically active peptides |
| 09/30/1992 | EP0505488A1 Polypeptide with type iv collagen cell adhesion, spreading and motility activity |
| 09/30/1992 | EP0505385A1 Anti-aggregatory peptides containing a mercaptan or sulfide moiety |
| 09/30/1992 | EP0505353A1 Fast printer with a particle trap in the paper channel. |
| 09/30/1992 | CN1064813A Methods and compositions for treatment and repair of defects or lesions in cartilage |
| 09/30/1992 | CA2107222A1 Fat substitute compositions having reduced laxative effects |
| 09/30/1992 | CA2107092A1 Virus inactivation method and pharmaceutical composition therefor |
| 09/29/1992 | WO1992017501A1 Isolated osteogenic factor |
| 09/29/1992 | WO1992017196A1 Anti-thrombotic peptides and pseudopeptides |
| 09/29/1992 | US5151499 Virus deactivated protein from plasma |
| 09/29/1992 | US5151498 Immunomodulators and mitogenic agents by extraction, precipitation and filtration |
| 09/29/1992 | US5151497 Histidyl peptide derivatives |
| 09/29/1992 | US5151438 Retroviral protease inhibiting compounds |
| 09/29/1992 | US5151433 Stabilized medicinal substances, a process for the preparation thereof, and stable medicinal formulations |
| 09/29/1992 | US5151432 Substituted amino acid compounds |
| 09/29/1992 | US5151412 Pharmaceutically active conjugates having improved body tissue binding specificity |
| 09/29/1992 | US5151364 Expression vectors containing lambdapl promoter, T1 T2 RRNA termination sequence, and origin of replication derived from a constitutive high copy number plasmid, and hosts containing the plasmids |
| 09/29/1992 | US5151355 Process for the production of high purity thrombin |
| 09/29/1992 | US5151350 Cloned genes encoding recombinant protein a |
| 09/29/1992 | US5151268 DNA cloning vectors for genetic engineering |
| 09/29/1992 | US5151266 Incubation an immunoreactive component with an anionic detergent and bonding, separation |
| 09/29/1992 | US5151265 Gamma interferon formulation |
| 09/29/1992 | CA2107106A1 Cross-linking agent |
| 09/29/1992 | CA2107088A1 Anti-thrombotic peptides and pseudopeptides |
| 09/29/1992 | CA2064114A1 Somatostatin receptor |
| 09/29/1992 | CA2061476A1 Peptifluorin and neopeptifluorin |
| 09/28/1992 | WO1992017192A1 Therapeutic fragments of von willebrand factor |
| 09/28/1992 | CA2107100A1 Therapeutic fragments of von willebrand factor |
| 09/28/1992 | CA2063035A1 Chimaeric antibodies containing the ligand domain of cd4 |
| 09/28/1992 | CA2039248A1 Ultra-pure thrombin preparation |
| 09/26/1992 | WO1992016551A1 Small peptidic compounds useful for the treatment of glaucoma |
| 09/26/1992 | WO1992016550A1 Organosulphur compounds useful for the treatment of glaucoma |
| 09/26/1992 | WO1992016548A1 Compositions which are immunologically crossreactive with antibodies and preparative methods therefor |
| 09/26/1992 | CA2106982A1 Compositions which are immunologically crossreactive with antibodies and preparative methods therefor |
| 09/26/1992 | CA2106860A1 Organosulphur compounds useful for the treatment of glaucoma |
| 09/26/1992 | CA2106858A1 Small peptidic compounds useful for the treatment of glaucoma |
| 09/24/1992 | DE4109254A1 Verwendung von apotransferrin, welches zweiwertige kationen angelagert hat, zur bekaempfung der toxischen wirkung des endotoxins Use of apotransferrin that has bound divalent cations to combat the toxic effect of endotoxins |
| 09/24/1992 | DE4108951A1 Immunostimulant for treating tumours, AIDS, leukaemia etc. - comprises extract of Eleuthero=coccus sentiocus, along with animal spleen and thymus |
| 09/23/1992 | WO1992016234A1 Method of modulating mammalian t-cell response |
| 09/23/1992 | EP0505148A1 Stimulating factor of the neu receptor |
| 09/23/1992 | EP0505123A1 Pulmonary administration of granulocyte colony stimulating factor |
| 09/23/1992 | EP0504938A2 Prophylactic and therapeutic agent for bone diseases comprising di- or tripeptide derivative as active ingredient |
| 09/23/1992 | EP0504919A2 Mirabilis jalapa antiviral protein |
| 09/23/1992 | EP0504760A1 Ciclosporin form for pulmonary administration |
| 09/23/1992 | EP0504483A1 Rectal compositions containing lyophilized calcitonin |
| 09/23/1992 | EP0504388A1 Varicella-zoster virus antigen |
| 09/23/1992 | EP0504363A1 PURIFIED IgG ANTIBODIES |
| 09/23/1992 | EP0504350A1 Antibodies directed against cd3 |
| 09/23/1992 | EP0504335A1 A fibronectin binding peptide |
| 09/23/1992 | EP0504327A1 Therapeutic uses of the hypervariable region of monoclonal antibody m195 and constructs thereof |
| 09/23/1992 | EP0504291A1 Novel proteins with oncostatin m activity and process for their preparation |
| 09/23/1992 | EP0504289A1 Cell-cycle-dependent regulation of phosphorylation of human retinoblastoma gene product |
| 09/23/1992 | EP0504257A1 [Ala IL-8] 77 AS A LEUKOCYTE ADHESION INHIBITOR |
| 09/23/1992 | EP0504241A1 Proteins and nucleic acids |
| 09/23/1992 | EP0504239A1 Anistreplase for treating stroke |
| 09/23/1992 | EP0504234A1 ANTIBODIES PREVENTING INTERACTION BETWEEN A FRAGMENT Fc OF AN IMMUNOGLOBULIN AND ITS RECEIVER, AND THERAPEUTIC USE, PARTICULARILY IN TREATING AFFECTIONS LINKED TO THE HIV VIRUS |
| 09/23/1992 | EP0504191A1 Method and composition for the treatment of mammalian hiv infection. |
| 09/23/1992 | EP0504177A1 A mammalian cytokine, il-11 |
| 09/23/1992 | EP0504168A1 Synthetic calcitonin peptides |
| 09/23/1992 | EP0227809B1 Process and composition for treatment of cancer and non-malignant tumors |
| 09/23/1992 | EP0211899B1 Purification of native colony stimulating factor-1 |
| 09/23/1992 | CN1064704A Curculin b and dna encoding same, and process for production thereof |
| 09/23/1992 | CN1064683A New beta-amino-alpha-hydroxycarboxylic acids and their use |
| 09/23/1992 | CA2106567A1 Method of modulating mammalian t-cell response |
| 09/22/1992 | WO1992016630A1 Dna sequences which code for virulence characteristics of streptococcus suis and parts thereof, polypeptides and antibodies derived therefrom and the use thereof for the diagnosis of and protection against infection by s. suis in mammals, including man |
| 09/22/1992 | WO1992016235A1 Compositions and methods of treatment of a variety of disorders utilizing etianate and agonists thereof |
| 09/22/1992 | US5149796 Chimeric DNA-RNA catalytic sequences |
| 09/22/1992 | US5149792 Recombinant protein comprising amino acids 1-119 of PDGF B109 precursor; mitogenesis at site of injured connective tissue; expressed from Escherichia host cells |
| 09/22/1992 | US5149787 Method for maintaining intact, non-degraded factor VIII/von-Willebrand factor during blood processing |
| 09/22/1992 | US5149786 Free of adrenal and brain derived proteins, useful for treating perkinson's disease and schizophrenia |
| 09/22/1992 | US5149782 Macromolecular drug linked to hydrophobic membrane blending agent for insertion; cleavably linked blocking agent |
| 09/22/1992 | US5149781 Steroid/thyroid hormone receptor-related gene inappropriately expressed in human hepatocellular carcinoma |
| 09/22/1992 | US5149780 60 to 90 amino acid residues in length, ability to prevent receptor mediated cell adhesion such as aggregation of platelets and fibroblasts to a matrix |
| 09/22/1992 | US5149778 Viricides; enzyme inhibitors |
| 09/22/1992 | US5149777 Human insulin analogs and preparations containing them |
| 09/22/1992 | US5149716 Insulin derivatives, process for their preparation, their use and a pharmaceutical preparation containing them |
| 09/22/1992 | US5149692 Bisalkoxyphosphinyl compounds as renin inhibitors |
| 09/22/1992 | US5149691 Applying to dental tissue; synergistic |
| 09/22/1992 | US5149650 Recombinant DNA, coding sequences, host cells |
| 09/22/1992 | US5149637 Recombinant Factor VIIIC fragments |
| 09/22/1992 | US5149544 Method of inhibiting progenitor cell proliferation |
| 09/22/1992 | US5149543 Ionically cross-linked polymeric microcapsules |
| 09/22/1992 | US5149540 Hemostatic agents |
| 09/22/1992 | US5149537 Suppository form; reducing calcium levels in blood; taurocholic acid as enhancer for calcitonin |
| 09/22/1992 | US5149533 Genetically engineered human tissue plasminogen activator having increased half-life, and increased clot lysis activity and greater specificity for binding fibrin |
| 09/22/1992 | US5149532 Transforming lactobacillus by recombinant DNA technology to express herpes virus glycoprotein D, growing lactobacillus in culture media, harvesting by separation |
| 09/22/1992 | US5149527 Administering to induce production of macrophages specifically cytotoxic for tumor cells |
| 09/22/1992 | CA2105378A1 Compositions and methods of treatment of a variety of disorders utilizing etianate and agonists thereof |
| 09/22/1992 | CA1307753C Dna sequences, recombinant dna molecules and processes for producing mullerian inhibiting substance-like polypeptides |
| 09/21/1992 | CA2063185A1 Benzo-fused lactams that promote the release of growth hormone |
| 09/20/1992 | WO1992016224A1 Improved fish production |
| 09/20/1992 | CA2038597A1 A method and a pharmaceutical preparation for treating pain |